Expertise in
9
conditions

Ulrike Peytavi-Blume

Charité Universitätsmedizin
Berlin, BE, DE 
Expertise in
9
conditions
Charité Universitätsmedizin
Berlin, BE, DE 

Overview

Ulrike Peytavi-Blume practices practicing medicine in Berlin, Germany.

Ms. Peytavi-Blume is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Alopecia Areata, Intertrigo, Acne, and Hormone Replacement Therapy (HRT).

She is actively involved in clinical research, co-authoring 288 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Charité Universitätsmedizin
Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 mo of Age) With Mild to Moderate Plaque Psoriasis
A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 mo of Age) With Mild to Moderate Plaque Psoriasis
Enrollment Status: Completed
Publish Date: February 18, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

288 Total Publications

Skin and Wound Infection Models to Test Host-Pathogen Interactions and Evaluate Topical Antimicrobial Treatments.
Skin and Wound Infection Models to Test Host-Pathogen Interactions and Evaluate Topical Antimicrobial Treatments.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 18, 2026

Frequently Asked Questions about Ulrike Peytavi-Blume

Is Ulrike Peytavi-Blume a top-rated expert for Autosomal Recessive Hypotrichosis?

MediFind is an objective health platform that identifies experts based on real-world data. Ulrike Peytavi-Blume is classified as an Elite expert for Autosomal Recessive Hypotrichosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ulrike Peytavi-Blume participate in research or clinical trials?

Yes. Ulrike Peytavi-Blume has published 288 articles and abstracts on conditions like Autosomal Recessive Hypotrichosis. You can view a list of Ulrike Peytavi-Blume's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Peytavi-Blume's expertise for a condition
ConditionClose
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile